ARK Invest has strategically intensified its focus on artificial intelligence, genomics, and clean energy. Recently, it acquired 83,764 shares of CoreWeave, Nvidia’s AI cloud partner, valued at approximately $6.9 million. This investment aligns with CoreWeave’s strong revenue growth and position within the $79 billion AI infrastructure market. Additionally, ARK made a significant move by purchasing nearly 349,000 shares in OpenAI, marking its inaugural direct investment in the innovator behind ChatGPT.
The firm also increased stakes in Kodiak AI, Oklo nuclear startup, and DoorDash, while adding shares in genomics companies Arcturus Therapeutics and GeneDx. Conversely, ARK sold 745,000 shares of Strata Critical Medical and reduced holdings in Teradyne, Pinterest, and others. Despite these maneuvers, ARKK lagged behind, down about 12% year-to-date with $1.2 billion in net outflows. For insights on emerging stocks, consider checking out Knockout Stocks for market trends and evaluations.
Source link
